CERE - Cerevel Therapeutics GAAP EPS of -$0.61 beats by $0.04
2023-11-01 06:31:38 ET
More on Cerevel Therapeutics
- Cerevel: Drop On Data Delay For EMPOWER Program Provides Buy Opportunity
- Cerevel Therapeutics prices $450M stock
- Cerevel downgraded at Bank of America on delayed readouts
- Seeking Alpha’s Quant Rating on Cerevel Therapeutics
- Historical earnings data for Cerevel Therapeutics
For further details see:
Cerevel Therapeutics GAAP EPS of -$0.61 beats by $0.04